Change over period: —
NSE · TARSONS
TARSONS
-17.5% from the 52-week high · +79.1% above the low
Tarsons Products Ltd. engages in the production and supply of laboratory plastic ware for use within molecular biology, cell culture, genomics, proteomics and immunology. The company is headquartered in Kolkata, West Bengal and currently employs 556 full-time employees. The company went IPO on 2021-11-26. The firm is engaged in designing, development, manufacturing and marketing of consumables, reusables and others including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies contract research organizations (CROs), diagnostic companies and hospitals. The firm is also engaged in the manufacturing of range a of labware products which helps scientific discovery and improve healthcare. The firm has developed a diverse range of labware products under the categories: consumables, reusables and others. The Company’s consumables products include pipette tips, centrifuge ware, petri dishes, cryo ware and storage vials. Its reusable products include bottles and carboys, beakers, cylinders and racks. Its other products include centrifuge, vortex and pipettors.
The short version. TARSONS reported revenue of ₹124 crore for Sep 2026, up 21.6% from a year earlier. Net profit was ₹0 crore (down 100.0% year on year). Return on equity was 2.3% in Mar 2026. Promoter holding was 47.3% in Sep 2026, down 0.01 points over 8 quarters.
1 · The price
How has the stock traded?
TARSONS trades 17.5% below its 52-week high and 79.1% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹124 cr.
3.5 pts lower than a year earlier.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 124 | 110 | 121 | 108 | 102 | 91 | 113 | 96 |
| Net profit | 0 | -1 | 4 | 5 | 3 | 2 | 10 | 5 |
| Net margin % | -0.3 | -1.3 | 3.5 | 4.7 | 3.2 | 2.0 | 9.1 | 5.5 |
| EPS (₹) | -0.06 | -0.27 | 0.79 | 0.95 | 0.62 | 0.34 | 1.92 | 0.99 |
Annual
| FY2026 | FY2025 | FY2024 | FY2022 | |
|---|---|---|---|---|
| Revenue | 423 | 392 | 296 | 301 |
| Net profit | 14 | 30 | 43 | 101 |
| Net margin % | 3.4 | 7.6 | 14.4 | 33.5 |
| EPS (₹) | 2.69 | 5.6 | 8.01 | 18.92 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 2.3% in Mar 2026; debt to equity is 0.60.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 2.3 | 4.7 | 7.0 | — |
| Return on capital % | 4.8 | 7.1 | 9.3 | — |
| EBITDA margin % | 31.6 | 31.0 | 36.1 | — |
| Net margin % | 3.2 | 7.3 | 13.9 | — |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | — | — |
| Profit CAGR | — | — |
4 · The owners
Who holds it, and are they adding?
Down 0.01 pts over 8 quarters.
Down 6.96 pts over 8 quarters.
Up 0.11 pts over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 47.31 | 47.31 | 47.31 | 47.31 | 47.3 | 47.3 | 47.3 | 47.3 | -0.01 |
| FII | 7.51 | 9.52 | 9.14 | 5.82 | 2.47 | 0.87 | 0.16 | 0.55 | -6.96 |
| DII | 0.5 | 0.29 | 0.04 | 0.08 | 0 | 0.19 | 0.1 | 0.61 | +0.11 |
| Public | 44.68 | 42.88 | 43.52 | 46.78 | 50.23 | 51.64 | 52.44 | 51.53 | +6.85 |
Mutual fund holdings · Oct 2026
2 schemes hold this stock
2 the month before.
- Motilal Oswal BSE Healthcare ETF0.03% of NAV
- Bandhan BSE Healthcare Index Fund0.03% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for TARSONS are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Healthcare Equipment & Supplies stocks
Quick answers
Common questions about TARSONS
What is the TARSONS share price?
TARSONS (TARSONS) last closed at ₹303.70, up 1.84% on the day. Its 52-week range is ₹166.46 to ₹361.50.
What is the market cap of TARSONS?
TARSONS has a market capitalisation of about ₹1,585 crore.
How are TARSONS's latest results?
TARSONS reported revenue of ₹124 crore for Sep 2026, up 21.6% from a year earlier. Net profit was ₹0 crore (down 100.0% year on year). Return on equity was 2.3% in Mar 2026. Promoter holding was 47.3% in Sep 2026, down 0.01 points over 8 quarters.
Who owns TARSONS?
As of Sep 2026, shareholding was: Promoter 47.3%, FII 0.55%, DII 0.61%, Public 51.53%.
How many mutual funds hold TARSONS?
2 mutual fund schemes held TARSONS in October 2026. That compares with 2 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 20 Sep 2024 · Final Dividend - Rs. 2
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.